HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas W Frazier Selected Research

Autism Spectrum Disorder

1/2022Editorial: Precision medicine approaches for heterogeneous conditions such as autism spectrum disorders (The need for a biomarker exploration phase in clinical trials - Phase 2m).
1/2021Evidence-based use of scalable biomarkers to increase diagnostic efficiency and decrease the lifetime costs of autism.
1/2020Developing more clinically useful biomarkers in autism spectrum disorder.
10/2019Neurobehavioral phenotype of autism spectrum disorder associated with germline heterozygous mutations in PTEN.
1/2019A Pivotal Response Treatment Package for Children With Autism Spectrum Disorder: An RCT.
2/2018A proton MR spectroscopy study of the thalamus in twins with autism spectrum disorder.
12/2016Sensing Technologies for Autism Spectrum Disorder Screening and Intervention.
2/2014Biochemical screening and PTEN mutation analysis in individuals with autism spectrum disorders and macrocephaly.
6/2010Effectiveness of medication combined with intensive behavioral intervention for reducing aggression in youth with autism spectrum disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas W Frazier Research Topics

Disease

9Autism Spectrum Disorder
01/2022 - 06/2010
6Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
07/2015 - 01/2007
5Autistic Disorder (Autism)
01/2022 - 02/2012
3Megalencephaly
10/2019 - 02/2014
3Bipolar Disorder (Manic Depressive Psychosis)
01/2012 - 05/2007
2Neoplasms (Cancer)
10/2019 - 07/2015
2Neurodevelopmental Disorders
10/2019 - 02/2014
2Mania (Manias)
06/2016 - 08/2011
2Attention Deficit and Disruptive Behavior Disorders (Disruptive Behavior Disorder)
11/2014 - 06/2011
2Cyclothymic Disorder
01/2012 - 05/2007
1Epilepsy (Aura)
03/2024
1Breast Neoplasms (Breast Cancer)
10/2019
1Language Development Disorders (Semantic-Pragmatic Disorder)
01/2019
1Multiple Hamartoma Syndrome (Cowden's Disease)
07/2015
1Thyroid Neoplasms (Thyroid Cancer)
07/2015
1Schizophrenia (Dementia Praecox)
11/2014
1Cognitive Dysfunction
11/2014
1Hypertrophy
06/2014
1Mood Disorders (Mood Disorder)
05/2014
1Mental Disorders (Mental Disorder)
08/2012
1Headache (Headaches)
01/2012
1Pain (Aches)
01/2012
1Psychotic Disorders (Schizoaffective Disorder)
08/2011
1Depressive Disorder (Melancholia)
06/2011

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2014
4Antipsychotic Agents (Antipsychotics)IBA
11/2014 - 06/2010
2TensinsIBA
10/2019 - 07/2015
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2019 - 07/2015
2Proteins (Proteins, Gene)FDA Link
07/2015 - 06/2014
2Aripiprazole (Abilify)FDA Link
01/2012 - 08/2011
2Methylphenidate (Ritalin)FDA LinkGeneric
10/2010 - 12/2009
2Indicators and Reagents (Reagents)IBA
09/2008 - 01/2007
1neodymium pyrocatechin disulfonate (NPD)IBA
01/2022
1EverolimusFDA Link
03/2021
1Lactic Acid (Lactate)FDA LinkGeneric
10/2019
1isocitric acid (isocitrate)IBA
10/2019
1FumaratesIBA
10/2019
1Succinate Dehydrogenase (Fumarate Reductase)IBA
10/2019
1Citric Acid (Citrate)FDA LinkGeneric
10/2019
1Protons (Proton)IBA
02/2018
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
07/2015
1TOR Serine-Threonine KinasesIBA
07/2015
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
07/2015
1Lisdexamfetamine DimesylateFDA Link
07/2015
1Antidepressive Agents (Antidepressants)IBA
11/2014
1Carisoprodol (Soma)FDA LinkGeneric
06/2014
1Brain-Derived Neurotrophic Factor (BDNF)IBA
05/2014
1AcidsIBA
02/2014
1AntioxidantsIBA
06/2012
1Acetylcysteine (Siran)FDA LinkGeneric
06/2012
1Risperidone (Risperdal Consta)FDA LinkGeneric
02/2012
1SodiumIBA
05/2007
1Valproic Acid (Depakote)FDA LinkGeneric
05/2007

Therapy/Procedure

5Therapeutics
03/2024 - 06/2011
1Precision Medicine
01/2022
1Treatment Delay
01/2019
1Transcranial Direct Current Stimulation
06/2016